drugset / Trial / NCT00005050

Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer

NCT00005050

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combining eniluracil, fluorouracil, and oxaliplatin in treating patients who have advanced colorectal cancer that has been treated previously.

Timeline

Start
1999-08
Primary completion
2001-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule Intravenous
Subject eniluracil Unknown Oral
Subject fluorouracil Small molecule Oral

Indications